glp-1 receptor agonist patient assistance programs Agonists and Other Drugs GLP-1 Receptor Agonists as Treatments

These patients take 0.04 0.12 mg/kg of insulin-like growth factor 1 twice daily subcutaneously, which is equal to at least 5.6 mg of the hormone per day for a 70 kg person

That study found zero serious adverse events in 42 healthy adults receiving standard research doses

Further longer term, larger scale and preferably multi-center studies are recommended to explore additional benefits, meanwhile it is prudent to advise L-carnitine supplementation for such patients

Annals Nutr Metab 70(2):106110

Amino acid restriction and ER stress are two major stresses which activate the ISR and both pathways converge on eIF2 14